Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP704949.RAG6pOfKH8SW6HYfQTdn7IIajgvE8GZkgSC6meT8ZA4O4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP704949.RAG6pOfKH8SW6HYfQTdn7IIajgvE8GZkgSC6meT8ZA4O4130_assertion type Assertion NP704949.RAG6pOfKH8SW6HYfQTdn7IIajgvE8GZkgSC6meT8ZA4O4130_head.
- NP704949.RAG6pOfKH8SW6HYfQTdn7IIajgvE8GZkgSC6meT8ZA4O4130_assertion description "[Frequently reported genome alterations were: the +3q27 and +8q24 mutations of TP53 for esophageal cancer; +20q13 for gastric cancer; -18q22 and +20q12-q13 mutations of APC, TP53 and KRAS for colorectal cancer, and the -18q22 mutation of KRAS and TP53 for pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP704949.RAG6pOfKH8SW6HYfQTdn7IIajgvE8GZkgSC6meT8ZA4O4130_provenance.
- NP704949.RAG6pOfKH8SW6HYfQTdn7IIajgvE8GZkgSC6meT8ZA4O4130_assertion evidence source_evidence_literature NP704949.RAG6pOfKH8SW6HYfQTdn7IIajgvE8GZkgSC6meT8ZA4O4130_provenance.
- NP704949.RAG6pOfKH8SW6HYfQTdn7IIajgvE8GZkgSC6meT8ZA4O4130_assertion SIO_000772 19023234 NP704949.RAG6pOfKH8SW6HYfQTdn7IIajgvE8GZkgSC6meT8ZA4O4130_provenance.
- NP704949.RAG6pOfKH8SW6HYfQTdn7IIajgvE8GZkgSC6meT8ZA4O4130_assertion wasDerivedFrom befree-2016 NP704949.RAG6pOfKH8SW6HYfQTdn7IIajgvE8GZkgSC6meT8ZA4O4130_provenance.
- NP704949.RAG6pOfKH8SW6HYfQTdn7IIajgvE8GZkgSC6meT8ZA4O4130_assertion wasGeneratedBy ECO_0000203 NP704949.RAG6pOfKH8SW6HYfQTdn7IIajgvE8GZkgSC6meT8ZA4O4130_provenance.